Skip to content

Public FDA record

Z-1077-2019: The UniCel DxI 600 and 800 Access Immunoassay Systems, that are connected to an automation line. UniCel

Recall record Z-1077-2019 for Beckman Coulter Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1077-2019
Company in FDA record
Beckman Coulter Inc.
FDA classification date
Mar 30, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

When racks are front-loaded onto the sample presentation unit while samples from the automation line are being processed, a scheduling error within the software can cause mishandling of samples during the creation of an aliquot and lead to incorrect results being generated. Affected samples typically yield non-reproducible falsely decreased results by up to 100%, however the potential for falsely elevated results cannot be ruled out.

Source facts

Action
On 12/05/18, the firm mailed Urgent Medical Device Recall notices to all consignees. In order to prevent this error from occurring, do not load racks onto the SPU while samples are being processed from the automation line. Either of the following options can be followed to avoid the error: 1) Pause the automation line before loading of any racks onto the SPU. a) To pause the automation line and load racks on the SPU, use the following steps: i) Set the Lab Automation System (LAS) Mode to "Offline" (1) Return to the Main Menu (F9) (2) Select Configure (F8) (3) Select LIS/LAS (F6) (4) Select LAS (F2) (5) In the dropdown menu, select "Offline" and press OK (F1) ii) Load samples onto the SPU iii) Wait until all racks from the SPU are fully aspirated and moved to the off-load area b) To resume processing using the automation line, follow Step (i) above and select "Online" from the dropdown menu. 2) As an alternative to pausing automation line operation, racks can be loaded onto the SPU of any stand-alone instrument (if available). - Interpret results in light of the total clinical presentation of the patient including: symptoms, clinical history, data from additional tests, and other appropriate information. - Review this letter with your Medical Director to determine if any further actions are warranted, including a review of results previously generated by affected systems. The firm will implement a correction in the next software release. Your service representative will contact you to schedule your software upgrade when available. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product(s) listed above to another laboratory, please provide them a copy of this letter. Customers were asked to complete and return the Response Form. Customers with additional questions were encouraged to call:1-800-854-363
Initiated
2018-12-05
Root cause
Under Investigation by firm
Distribution
US: NJ, OH, NY, GA, FL, TN, WI, MI, MS, CA, NC, TX, PA, DC, IN, KY, IL, WA, MN, LA, ND, ID, WV, AK, AL, MA. OUS: Argentina, Australia, Bahrain, Canada, China, Croatia, Czech Republic, Egypt, Germany, Greece, India, Italy, Malaysia, Morocco, Netherlands, Nigeria, Poland, Portugal, Qatar, Saudi Arabia, Singapore, South Africa, Spain, Switzerland, Thailand, Tunisia, United Kingdom, United States, Vietnam
Recall number
Z-1077-2019
Recall status
Open, Classified
CDRH record ID
170859
FDA classified
2019-03-30
Recall event number
82079

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗